Nephrology
Home Page
Xagena Medicine
Xagena.net
Kidney-pancreas transplant patients: metabolic syndrome is a risk factor
Kidney carcinoma: partial nephrectomy linked to improved quality of life and better preservation of long-term kidney function
End-stage renal disease: obesity is a risk factor
Hypertension linked to variation in dopamine receptor gene
End-stage kidney failure: nocturnal dialysis improves heart disease
End-stage renal disease: patients with type 1 diabetes have an improved prognosis
Kidney transplant patients linked to higher cancer risk
Hemodialysis: Heparin antibodies linked to more adverse outcomes
Benign prostate obstruction associated with kidney disease
Chronic kidney disease associated with APOE gene variant
Prevention of diabetes-related kidney disease: RAS blockers
Paricalcitor for earlier treatment of kidney disease complication, FDA approved
Dialysis patients: cholesterol proteins associated with cardiovascular risk
Next Pages [
1
]
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions